We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

209 hedge funds and large institutions have $2.95B invested in NEVRO CORP. in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 79 increasing their positions, 58 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 25

36% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 58

8% more funds holding

Funds holding: 194209 (+15)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

27% less call options, than puts

Call options by funds: $25.2M | Put options by funds: $34.3M

32% less capital invested

Capital invested by funds: $4.37B → $2.95B (-$1.41B)

Holders
209
Holders Change
+15
Holders Change %
+7.73%
% of All Funds
3.22%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
43
Increased
79
Reduced
58
Closed
25
Calls
$25.2M
Puts
$34.3M
Net Calls
-$9.13M
Net Calls Change
-$4.33M
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
76
Renaissance Technologies
New York
$3.53M +$4.36M +43,500 New
Envestnet Asset Management
77
Envestnet Asset Management
Illinois
$3.48M -$558K -5,570 -11%
ACM
78
Altium Capital Management
New York
$3.4M -$902K -9,000 -18%
Assenagon Asset Management
79
Assenagon Asset Management
Luxembourg
$3.34M +$4.12M +41,148 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
80
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$3.3M +$4.08M +40,700 New
Russell Investments Group
81
Russell Investments Group
United Kingdom
$3.19M +$2.84M +28,306 +255%
UBS AM
82
UBS AM
Illinois
$3.06M +$35K +349 +0.9%
BA
83
Bridgewater Associates
Connecticut
$3.01M +$477K +4,758 +15%
RhumbLine Advisers
84
RhumbLine Advisers
Massachusetts
$2.91M -$67.7K -676 -2%
Federated Hermes
85
Federated Hermes
Pennsylvania
$2.87M +$3.55M +35,446 New
IHAM
86
Integral Health Asset Management
New York
$2.84M +$501K +5,000 +17%
N
87
Natixis
France
$2.75M +$501K +5,000 +17%
SG Americas Securities
88
SG Americas Securities
New York
$2.63M +$1.65M +16,436 +103%
State of New Jersey Common Pension Fund D
89
State of New Jersey Common Pension Fund D
New Jersey
$2.62M +$817K +8,149 +34%
Truist Financial
90
Truist Financial
North Carolina
$2.3M -$804K -8,027 -22%
Qube Research & Technologies (QRT)
91
Qube Research & Technologies (QRT)
United Kingdom
$2.27M +$2.81M +28,009 New
ETC
92
Exchange Traded Concepts
Oklahoma
$2.23M +$337K +3,363 +14%
JRP
93
Jasper Ridge Partners
California
$2.11M
New York State Common Retirement Fund
94
New York State Common Retirement Fund
New York
$2.03M -$6.91K -69 -0.3%
EVM
95
Eaton Vance Management
Massachusetts
$2.01M +$30.5K +304 +1%
Ameriprise
96
Ameriprise
Minnesota
$2M +$57.5K +574 +2%
Wells Fargo
97
Wells Fargo
California
$1.98M -$427K -4,259 -15%
PA
98
Perceptive Advisors
New York
$1.86M -$23.8M -237,026 -91%
MOACM
99
Mutual of America Capital Management
New York
$1.82M -$21K -210 -0.9%
CAM
100
Connacht Asset Management
New York
$1.8M +$869K +8,674 +64%

NVRO Hedge Fund Activity: Q4 2021 in Review

209 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q4 2021, worth a combined $2.95B — down 32% from $4.37B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new NVRO positions and 25 closed out — a net gain of 18 holders — while 79 added to existing stakes and 58 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $84.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $235M.

  • 209 institutional investors held NEVRO CORP. (NVRO) as of Q4 2021, up from 194 in Q3 2021.
  • Funds reported $2.95B of NEVRO CORP. stock for Q4 2021, down 32% quarter-over-quarter.
  • 43 funds opened new NEVRO CORP. positions in Q4 2021 and 25 closed out, a net change of +18 holders.
  • The largest NEVRO CORP. buyer in Q4 2021 was Wellington Management Group, an estimated $84.5M added.
  • The largest NEVRO CORP. seller in Q4 2021 was T. Rowe Price Associates, an estimated $235M sold.

Based on aggregated 13F filings for Q4 2021.